Paternally inherited IGF2 mutation and growth restriction

New England Journal of Medicine

Volumn 373, Issue 4, 2015, Pages 349-356

  Begemann, Matthias ^a   Zirn, Birgit ^b   Santen, Gijs ^f   Wirthgen, Elisa ^c   Soellner, Lukas ^a   Büttel, Hans Martin ^d   Schweizer, Roland ^e   Van Workum, Wilbert ^f,g   Binder, Gerhard ^e   Eggermann, Thomas ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c Ligandis   (Germany)

^d SLK Kliniken Heilbronn   (Germany)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g ServiceXS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN B; IGF2 PROTEIN, HUMAN; STOP CODON;

ADOLESCENT; ADULT; AMBIGUOUS GENITALIA; ARTICLE; CASE REPORT; CHILD; CRYPTORCHISM; DISEASE SEVERITY; FEMALE; GROWTH RETARDATION; HUMAN; IGF2 GENE; INHERITANCE; INTRAUTERINE GROWTH RETARDATION; MACROCEPHALY; MALE; MUSCLE HYPOTONIA; NONSENSE MUTATION; PATHOGENICITY; PHENOTYPE; POSTNATAL GROWTH; POSTNATAL GROWTH RESTRICTION; PRENATAL GROWTH; PRIORITY JOURNAL; SCHOOL CHILD; SILVER RUSSELL SYNDROME; YOUNG ADULT; DEFICIENCY; FATHER; GENETICS; GROWTH DISORDER; NEWBORN; PEDIGREE; STOP CODON;

CODON, NONSENSE; FATHERS; FEMALE; FETAL GROWTH RETARDATION; GROWTH DISORDERS; HUMANS; INFANT, NEWBORN; INSULIN-LIKE GROWTH FACTOR II; MALE; PEDIGREE; PHENOTYPE; SILVER-RUSSELL SYNDROME;

EID: 84937875387     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1415227     Document Type: Article

References (24)

1. Gicquel C, Le Bouc Y. Hormonal regulation of fetal growth. Horm Res 2006; 65: Suppl 3:28-33.
2. Cohen P. Overview of the IGF-I system. Horm Res 2006; 65: Suppl 1: 3-8.
3. Baker J, Liu JP, Robertson EJ, Efstra-tiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993;75:73-82.
4. Fowden AL. The insulin-like growth factors and feto-placental growth. Placenta 2003;24:803-12.
5. Netchine I, Azzi S, Le Bouc Y, Savage MO. IGF1 molecular anomalies demonstrate its critical role in fetal, postnatal growth and brain development. Best Pract Res Clin Endocrinol Metab 2011; 25: 181-90.
6. Klammt J, Kiess W, Pfäff le R. IGF1R mutations as cause of SGA. Best Pract Res Clin Endocrinol Metab 2011; 25: 191-206.
7. Wakeling EL, Amero SA, Alders M, et al. Epigenotype-phenotype correlations in Silver-Russell syndrome. J Med Genet 2010;47:760-8.
8. Abuzzahab MJ, Schneider A, Goddard A, et al. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 2003; 349: 2211-22.
9. Woods KA, Camacho-Hübner C, Bergman RN, Barter D, Clark AJ, Savage MO. Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion. J Clin Endocrinol Metab 2000; 85: 1407-11.
10. Bonapace G, Concolino D, Formicola S, Strisciuglio P. A novel mutation in a patient with insulin-like growth factor 1 (IGF1) deficiency. J Med Genet 2003; 40: 913-7.
11. Netchine I, Azzi S, Houang M, et al. Partial primary deficiency of insulin-like growth factor (IGF)-I activity associated with IGF1 mutation demonstrates its critical role in growth and brain development. J Clin Endocrinol Metab 2009; 94: 3913-21.
12. Wit JM, Walenkamp MJ. Role of insulin-like growth factors in growth, development and feeding. World Rev Nutr Diet 2013;106:60-5.
13. DeChiara TM, Efstratiadis A, Robertson EJ. A growth-deficiency phenotype in heterozygous mice carrying an insulinlike growth factor II gene disrupted by targeting. Nature 1990;345:78-80.
14. DeChiara TM, Robertson EJ, Efstrati-adis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 1991;64:849-59.
15. Giannoukakis N, Deal C, Paquette J, Goodyer CG, Polychronakos C. Parental genomic imprinting of the human IGF2 gene. Nat Genet 1993; 4: 98-101.
16. Ekström TJ, Cui H, Li X, Ohlsson R. Promoter-specific IGF2 imprinting status and its plasticity during human liver development. Development 1995;121:309-16.
17. Gicquel C, Rossignol S, Cabrol S, et al. Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nat Genet 2005; 37: 1003-7.
18. Binder G, Seidel AK, Weber K, et al. IGF-II serum levels are normal in children with Silver-Russell syndrome who frequently carry epimutations at the IGF2 locus. J Clin Endocrinol Metab 2006; 91: 4709-12.
19. Cole TJ, Green PJ. Smoothing reference centile curves: the LMS method and penalized likelihood. Stat Med 1992; 11: 1305-19.
20. Niklasson A, Albertsson-Wikland K. Continuous growth reference from 24th week of gestation to 24 months by gender. BMC Pediatr 2008;8:8.
21. Eggermann T, Spengler S, Gogiel M, Begemann M, Elbracht M. Epigenetic and genetic diagnosis of Silver-Russell syndrome. Expert Rev Mol Diagn 2012; 12: 459-71.
22. Blum WF, Ranke MB, Bierich JR. A specific radioimmunoassay for insulinlike growth factor II: the interference of IGF binding proteins can be blocked by excess IGF-I. Acta Endocrinol (Copenh) 1988;118:374-80.
23. Godfrey KM, Barker DJ. Fetal programming and adult health. Public Health Nutr 2001;4:611-24.
24. Brioude F, Oliver-Petit I, Blaise A, et al. CDKN1C mutation affecting the PC-NA-binding domain as a cause of familial Russell Silver syndrome. J Med Genet 2013;50:823-30.